JP2021531345A5 - - Google Patents
Info
- Publication number
- JP2021531345A5 JP2021531345A5 JP2021526188A JP2021526188A JP2021531345A5 JP 2021531345 A5 JP2021531345 A5 JP 2021531345A5 JP 2021526188 A JP2021526188 A JP 2021526188A JP 2021526188 A JP2021526188 A JP 2021526188A JP 2021531345 A5 JP2021531345 A5 JP 2021531345A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- antigen
- combination product
- optionally
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18183694 | 2018-07-16 | ||
| EP18183694.1 | 2018-07-16 | ||
| EP19170999.7 | 2019-04-25 | ||
| EP19170999 | 2019-04-25 | ||
| PCT/NL2019/050451 WO2020017962A1 (en) | 2018-07-16 | 2019-07-16 | A combination product for use in tumor vaccination. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531345A JP2021531345A (ja) | 2021-11-18 |
| JP2021531345A5 true JP2021531345A5 (https=) | 2022-07-12 |
Family
ID=67544309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526188A Pending JP2021531345A (ja) | 2018-07-16 | 2019-07-16 | 腫瘍ワクチン接種に用いるための組合せ製品 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11071778B2 (https=) |
| EP (1) | EP3823668A1 (https=) |
| JP (1) | JP2021531345A (https=) |
| CA (1) | CA3104833A1 (https=) |
| WO (1) | WO2020017962A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020524710A (ja) | 2017-06-23 | 2020-08-20 | パソヴァックス エルエルシー | 免疫応答の抗原特異的リダイレクターとしてのキメラウイルス様粒子およびその使用 |
| WO2020017962A1 (en) | 2018-07-16 | 2020-01-23 | Dcprime B.V. | A combination product for use in tumor vaccination. |
| AU2019414934A1 (en) | 2018-12-27 | 2021-06-24 | Verimmune Llc | Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors |
| CA3133410A1 (en) | 2019-04-25 | 2020-10-29 | Dcprime B.V. | Methods of tumor vaccination |
| CN115916963A (zh) | 2020-03-27 | 2023-04-04 | 门德斯有限公司 | 白血病来源的经修饰细胞用于增强过继性细胞治疗的效力的离体用途 |
| US20210322471A1 (en) * | 2020-03-27 | 2021-10-21 | Dcprime B.V. | In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
| EP4171617A1 (en) | 2020-06-30 | 2023-05-03 | Mendus B.V. | Use of leukemia-derived cells in ovarian cancer vaccines |
| CA3195963A1 (en) | 2020-10-19 | 2022-04-28 | Joshua Weiyuan WANG | Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer |
| CA3196677A1 (en) * | 2020-11-05 | 2022-05-12 | Erik Hans MANTING | Use of tumor-independent antigens in immunotherapies |
| JP2024506249A (ja) | 2021-01-22 | 2024-02-13 | メンドゥス・ベスローテン・フェンノートシャップ | 腫瘍ワクチン接種の方法 |
| WO2024197451A1 (en) * | 2023-03-24 | 2024-10-03 | Virogin Biotech (Shanghai) Ltd. | Homologous and heterologous therapeutic vaccination strategies for cancer treatment |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US5667786A (en) | 1995-06-07 | 1997-09-16 | Novavax, Inc. | Method for treating tumors with a toxin |
| GB9905911D0 (en) | 1999-03-15 | 1999-05-05 | Photocure As | Method |
| WO2001049317A2 (en) | 2000-01-05 | 2001-07-12 | Aventis Pasteur Limited | Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| US7118740B1 (en) * | 2000-09-22 | 2006-10-10 | Mayo Foundation For Medical Education And Research | Method for limiting the growth of cancer cells using an attenuated measles virus |
| PT1346059E (pt) | 2000-11-29 | 2012-06-01 | Pci Biotech As | Internalização fotoquímica para distribuição de moléculas no citosol |
| EP1339862B1 (en) | 2000-11-29 | 2014-01-08 | PCI Biotech AS | Photochemical internalization for virus-mediated molecule delivery into the cytosol |
| CA2439111A1 (en) | 2001-04-05 | 2002-10-17 | Chiron Corporation | Mucosal boosting following parenteral priming |
| GB0121023D0 (en) | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
| US20040057935A1 (en) | 2002-09-20 | 2004-03-25 | Cedars-Sinai Medical Center | Intratumoral delivery of dendritic cells |
| JP2006232761A (ja) | 2005-02-25 | 2006-09-07 | Osaka Univ | 制癌剤 |
| AU2006260240B2 (en) | 2005-06-21 | 2012-03-15 | The Research Foundation For Microbial Diseases Of Osaka University | Therapeutic agent for cancer |
| US8476419B2 (en) | 2007-09-14 | 2013-07-02 | Vrije Universiteit Brussel | Enhancing the T-cells stimulatory capacity of human antigen presenting cells and their use in vaccination |
| WO2009127988A1 (en) | 2008-04-16 | 2009-10-22 | Universite De Lausanne | Method and vaccine for optimizing the specific immune responses |
| WO2009019320A2 (en) | 2008-05-19 | 2009-02-12 | Dcprime B.V. | Method for inducing and accelerating cells |
| GB0914286D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
| CN103179952B (zh) | 2010-09-02 | 2015-06-03 | 斯克里普斯研究学院 | 基于纳米颗粒的肿瘤靶向药物递送 |
| GB201106357D0 (en) * | 2011-04-14 | 2011-06-01 | Pessi Antonello | Composition and uses thereof |
| NL2009102C2 (en) | 2012-07-02 | 2014-01-06 | Dcprime B V | Method for dc-loading. |
| EP2743344A1 (en) | 2012-12-11 | 2014-06-18 | DCPrime B.V. | Therapeutic cancer vaccines derived from a novel dendritic cell line |
| WO2014138314A1 (en) | 2013-03-05 | 2014-09-12 | Baylor College Of Medicine | Oncolytic virus |
| US9974848B2 (en) | 2013-11-14 | 2018-05-22 | Duke University | Tetanus toxoid and CCL3 improve DC vaccines |
| GB201519303D0 (en) * | 2015-11-02 | 2015-12-16 | Imp Innovations Ltd | Phagemid vector |
| BR112019001115A2 (pt) * | 2016-07-21 | 2019-06-25 | Vac4All Pte Ltd | proteínas de biofusão como vacinas anti-malária |
| WO2020017962A1 (en) | 2018-07-16 | 2020-01-23 | Dcprime B.V. | A combination product for use in tumor vaccination. |
-
2019
- 2019-07-16 WO PCT/NL2019/050451 patent/WO2020017962A1/en not_active Ceased
- 2019-07-16 CA CA3104833A patent/CA3104833A1/en active Pending
- 2019-07-16 JP JP2021526188A patent/JP2021531345A/ja active Pending
- 2019-07-16 EP EP19749853.8A patent/EP3823668A1/en not_active Withdrawn
-
2020
- 2020-04-24 US US16/858,326 patent/US11071778B2/en active Active
-
2021
- 2021-06-29 US US17/361,462 patent/US20220023406A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531345A5 (https=) | ||
| Jin et al. | Nanoparticle‐mediated delivery of inhaled immunotherapeutics for treating lung metastasis | |
| CN112384205B (zh) | 信使rna疫苗及其用途 | |
| Makidon et al. | Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine | |
| Caldeira et al. | Virus-like particles as an immunogenic platform for cancer vaccines | |
| Raghuwanshi et al. | Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein | |
| US20230390389A1 (en) | Nucleic Acid Vaccine Composition Comprising a Lipid Formulation, and Method of Increasing the Potency of Nucleic Acid Vaccines | |
| Su et al. | Induction of mucosal immunity through systemic immunization: Phantom or reality? | |
| Lee et al. | Polymer structure and conformation alter the antigenicity of virus-like particle–polymer conjugates | |
| Lin et al. | Programmable macrophage vesicle based bionic self‐adjuvanting vaccine for immunization against monkeypox virus | |
| KR102359691B1 (ko) | 재조합 리스테리아 백신 균주 및 그 생산 방법 | |
| JP2019536464A5 (https=) | ||
| JP2011519869A5 (https=) | ||
| WO2008019366A3 (en) | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens | |
| JP2018536002A5 (https=) | ||
| Bandara et al. | Current landscape and future directions in cancer immunotherapy: therapies, trials, and challenges | |
| JP2007211026A (ja) | パピロマウイルス偽ウイルス及びその調製方法 | |
| JP2022530044A5 (https=) | ||
| CN103768595B (zh) | 唑来膦酸佐剂及含唑来膦酸佐剂的疫苗 | |
| Chakraborty et al. | Ongoing clinical trials of vaccines to fight against COVID-19 pandemic | |
| JP2024525994A5 (https=) | ||
| Cossette et al. | Intranasal subunit vaccination strategies employing nanomaterials and biomaterials | |
| Zhang et al. | Bivalent circular RNA vaccines against porcine epidemic diarrhea virus and transmissible gastroenteritis virus | |
| Lokras et al. | Cholesterol in mRNA‐Lipid Nanoparticles can be Replaced with the Synthetic Mycobacterial Monomycoloyl Glycerol Analogue MMG‐1 | |
| JP2019534897A5 (https=) |